Research grants are a great source of non-dilutive capital that can enable you to further de-risk the science and technology that serve as the foundation of your business. Additionally, they can be an effective way to externally validate your ideas and research plan. The challenge is that the grant review process can be lengthy and there are limitations on what the funds can be used for. Tips on obtaining small business grants are included here.
Notification of Phase 1 Grant Solicitations
National Science Foundation (NSF) SBIR & STTR Grants
SBIR Phase I Solicitation (NSF 14-603): Deadline is December 2, 2014
STTR Phase I Solicitaion (NSF 14-540): Deadline is December 4, 2014
Computer & Information Science & Engineering
Education and Human Resources
Environmental Research & Education
International & Integrative Activities
Mathematical & Physical Sciences
Social, Behavioral & Economic Sciences
For more information on Q&A Webinars: SBIR/STTR Phase I Q&A Webinars
2014 SBIR/STTR Omnibus announcement
The 2014 Omnibus Grant Solicitations of the NIH, CDC, FDA and ACF are now available for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Please note that applicants may now switch between the SBIR and STTR programs for the Omnibus solicitation and all NIH SBIR/STTR funding opportunity announcements (FOAs). A FOA for a Direct SBIR Phase II will be coming soon-- stay tuned to the NIH SBIR homepage for details.
Please find the 2014 SBIR/STTR Omnibus solicitations and accompanying resources below:
Standard Application Due Date: December 5, 2014.
AIDS and AIDS-related Application Due Date: January 7, 2015.
Small business concerns (SBCs) may also check the Special Announcements Table on the NIH SBIR website
for targeted NIH SBIR/STTR FOAs issued by individual Institutes and Centers (ICs).
HHS Grant Announcements
CDC: Strengthening HIV Strategic Information Activities in the Republic of Senegal under the President's Emergency Plan for AIDS Relief (PEPFAR) Modification 1 (CDC-RFA-GH15-1573)
NIH: Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01) Grant (RFA-DK-14-023)
CDC: Increasing Capacity of the Dominican Republic Ministry of Health in the Areas of Blood Safety, Monitoring and Evaluation, Epidemiology, and Health Information Systems under the President's Emergency Plan for AIDS Relief (PEPFAR) Modification 1 (CDC-RFA-GH15-1518)
NIH: Brain Somatic Mosaicism and its Role in Psychiatric Disorders (Collaborative U01) Grant (PAR-15-022)
Grand Challenges: New Interventions for Global Health
The Bill & Melinda Gates Foundation is launching a new Grand Challenge: New Interventions for Global Health. This challenge focuses on innovative concepts for vaccines, therapeutics, and diagnostics with the potential to be translated into safe, effective, affordable, and widely utilized interventions to protect against acquisition, progression, or transmission of infectious diseases, or to provide a cure for infectious diseases, in resource-limited settings.
This request for proposals will fund awards that could include grants, program related investments, or contracts up to USD $10,000,000 per awardee for up to four years. Full awards must include an industry, biotech, or other translational partner, either leading or participating in the application. Applications for pilot awards up to USD $2,000,000 are also considered.
Application deadline is January 13, 2015. For detailed description of this challenge, see the Request for Proposals.
ONC Market R&D Pilot Challenge
The Market R&D Pilot Challenge, brought to you by the Office of National Coordinator for Health Information Technology (ONC), will help bridge technological gaps by bringing together health care organizations and innovative companies through $300,000 in pilot funding awards and facilitated matchmaking. The Challenge may award pilot proposals across the four domains:
- Clinical environments, such as hospitals, ambulatory care, surgical centers
- Public Health and community environments with community-based personnel such as public health departments, community health workers, mobile medical trucks and school-based clinic
- Consumer health, such as pharmacies and laboratories
- Research and data that, for example, provide novel ways of collecting data from patients
The Host and Innovator co-applicants must discuss and agree upon the pilot project prior to submitting an application. To apply, jointly complete the Joint Proposal Form by March 2, 2015.
For more information visit www.oncpilotchallenge.com
NIH's SBIR/STTR Niche Assessment Program
The NIH’s SBIR/STTR Niche Assessment Program (NAP) is a nationwide program to help jump-start an SBIR/STTR Phase I awardee's commercialization efforts. Technology Niche Analyses® are provided by Foresight for 138 NIH SBIR/STTR Phase I awardees. These analyses are often awarded on a first come, first served basis and assess potential applications for a technology and then for one viable application, it provides an assessment of the:
1. needs and concerns of end-users;
2. competing technologies and competing products;
3. competitive advantage of the SBIR/STTR-developed technology;
4. market size and potential market
5. barriers to market entry (pricing, competition, government regulations, manufacturing challenges, capital, etc.);
6. market drivers;
7. status of market and industry trends;
8. potential customers, licensees, investors, or other commercialization partners; and,
9. the price customers are likely to pay.
Each participant receives an in-depth report. Oftentimes the small business can use this information in their commercialization plans for their Phase II applications. For more information, see Notice NOT-OD-13-109 that was placed in the NIH Guide for Grants and Contracts on August 28, 2013.